4//SEC Filing
Leproust Emily M. 4
Accession 0001214659-25-017002
CIK 0001581280other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:05 PM ET
Size
12.8 KB
Accession
0001214659-25-017002
Insider Transaction Report
Form 4
Leproust Emily M.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-11-18+146,914→ 880,836 total
Holdings
- 0
Employee Stock Option (right to buy)
Exercise: $5.95Exp: 2025-09-28→ Common Stock (0 underlying) - 150,879
Employee Stock Option (right to buy)
Exercise: $8.82Exp: 2027-09-28→ Common Stock (0 underlying) - 266,539
Employee Stock Option (right to buy)
Exercise: $26.66Exp: 2028-11-18→ Common Stock (0 underlying) - 131,290
Employee Stock Option (right to buy)
Exercise: $23.33Exp: 2029-10-23→ Common Stock (0 underlying) - 64,950
Employee Stock Option (right to buy)
Exercise: $67.85From: 2022-12-19Exp: 2030-08-31→ Common Stock (64,950 underlying)
Footnotes (6)
- [F1]Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2025 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
- [F2]The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F3]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F4]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F5]25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
- [F6]Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
Documents
Issuer
Twist Bioscience Corp
CIK 0001581280
Entity typeother
Related Parties
1- filerCIK 0001753655
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:05 PM ET
- Size
- 12.8 KB